PYRAMID registry: An observational study of adalimumab in Crohn's disease: results at year 3

被引：3
|
作者：
D'Haens, Geert [1 ]
Reinisch, Walter [2 ]
Satsangi, Jack [3 ]
Loftus, Edward [4 ]
Panaccione, Remo [5 ]
Tokimoto, Debbie
Wang, Yaqin
Lomax, Kathleen
机构：
[1] Univ Amsterdam, Acad Med Ctr, Ctr Inflammatory Bowel Dis, NL-1105 AZ Amsterdam, Netherlands
[2] Med Univ Vienna, Vienna, Austria
[3] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Mayo Clin, Rochester, MN USA
[5] Univ Calgary, Calgary, AB T2N 1N4, Canada
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
10.1097/00054725-201112002-00068
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry
    D'Haens, Geert
    Reinisch, Walter
    Panaccione, Remo
    Satsangi, Jack
    Petersson, Joel
    Bereswill, Mareike
    Arikan, Dilek
    Perotti, Eva
    Robinson, Anne M.
    Kalabic, Jasmina
    Alperovich, Gabriela
    Thakkar, Roopal
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (06): : 872 - 882
  • [42] Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry
    Canete, Fiorella
    Manosa, Miriam
    Casanova, Maria Jose
    Gonzalez-Sueyro, Ramiro C.
    Barrio, Jesus
    Bermejo, Fernando
    Nos, Pilar
    Iglesias-Flores, Eva
    Garcia-Planella, Esther
    Lazaro Perez-Calle, Jose
    Vicente, Raquel
    Vera, Maribel
    Ramos, Laura
    Rivero, Montserrat
    De Francisco, Ruth
    Montserrat, Antonia
    Benitez, Olga
    Navarro, Pablo
    Taxonera, Carlos
    Hinojosa, Esther
    Marquez-Mosquera, Lucia
    Navarro-Llavat, Merce
    Ramirez-de La Piscina, Patricia
    Gomollon, Fernando
    Rodriguez-Alonso, Lorena
    Nunez-Alonso, Alejandro
    Fernandez-Salazar, Luis
    Almela, Pedro
    Rios Leon, Raquel
    De Castro, Luisa
    Gisbert, Javier P.
    Ricart, Elena
    Cabre, Eduard
    Domenech, Eugeni
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (11) : 1862 - 1870
  • [43] Adalimumab for the treatment of Crohn's disease
    Cassinotti, Andrea
    Ardizzone, Sandro
    Porro, Gabriele Bianchi
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 763 - 777
  • [44] Adalimumab for the treatment of Crohn's disease
    Devlin, Shane M.
    Panaccione, Remo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) : 1011 - 1019
  • [45] Pharmacokinetics of adalimumab in Crohn’s disease
    David Ternant
    Konstantinos Karmiris
    Severine Vermeire
    Céline Desvignes
    Nicolas Azzopardi
    Theodora Bejan-Angoulvant
    Gert van Assche
    Gilles Paintaud
    European Journal of Clinical Pharmacology, 2015, 71 : 1155 - 1157
  • [46] Adalimumab induction for Crohn's disease
    Cottone, M
    Mocciaro, F
    Scimeca, D
    GASTROENTEROLOGY, 2006, 130 (06) : 1929 - 1929
  • [47] Adalimumab in pediatric Crohn's disease
    Patel, Ashish S.
    Suarez, Lisbet D.
    Rosh, Joel R.
    IMMUNOTHERAPY, 2016, 8 (02) : 127 - 133
  • [48] Pharmacokinetics of adalimumab in Crohn's disease
    Ternant, David
    Karmiris, Konstantinos
    Vermeire, Severine
    Desvignes, Celine
    Azzopardi, Nicolas
    Bejan-Angoulvant, Theodora
    van Assche, Gert
    Paintaud, Gilles
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (09) : 1155 - 1157
  • [49] Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study ICC Registry - Vedolizumab
    Biemans, Vince B. C.
    van der Woude, C. Janneke
    Dijkstra, Gerard
    van der Meulen-de Jong, Andrea E.
    Oldenburg, Bas
    de Boer, Nanne K.
    Loewenberg, Mark
    Srivastava, Nidhi
    Bodelier, Alexander G. L.
    West, Rachel L.
    Jansen, Jeroen M.
    de Vries, Annemarie C.
    Haans, Jeoffrey J. L.
    de Jong, Dirk J.
    Pierik, Marie J.
    Hoentjen, Frank
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (05) : 1189 - 1199
  • [50] Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study
    Hisamatsu, Tadakazu
    Suzuki, Yasuo
    Kobayashi, Mariko
    Hagiwara, Takashi
    Kawaberi, Takeshi
    Ogata, Haruhiko
    Matsui, Toshiyuki
    Watanabe, Mamoru
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2021, 19 (04) : 408 - 418
12345